Scientist Training in Rheumatology Research
风湿病学研究科学家培训
基本信息
- 批准号:10627099
- 负责人:
- 金额:$ 35.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1976
- 资助国家:美国
- 起止时间:1976-07-01 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
PROJECT SUMMARY / ABSTRACT
This application is a competitive renewal of the University of Michigan's Program for Scientist Training in
Rheumatology Research (T32AR007080). Our Program, funded by NIAMS since 1975, is designed to
prepare four outstanding postdoctoral scientists per year, both MD and PhD, for investigative careers in
research related to the rheumatic diseases. Our Program is motivated by several key factors including (i) the
tremendous clinical need caused by the unrelenting burden of rheumatic diseases; (ii) an appreciation that
rheumatic diseases are propelled by complex processes in need of multidisciplinary approaches; and (iii) a
threatened pipeline of diverse investigators committed to careers that will be devoted to rheumatology
research. Fortunately, recent advances in biomedical and clinical sciences have created unprecedented
research opportunities to understand disease etiologies more deeply—and ultimately improve outcomes
through an approach personalized to the care of each individual living with a rheumatic disease. Our 22
Program faculty mentors are dedicated researcher-mentors who together bring broad interdisciplinary
expertise focused on rheumatic diseases. These investigators have established extensive collaborations with
research units nationally and internationally to effectively study rheumatic disease mechanisms and improve
management. Leveraging these historical strengths, our Program's themes have been updated to align with
NIAMS strategic mission “to transcend disease- and tissue-specific boundaries via cross-cutting scientific
themes.” For the upcoming cycle of our Program, major scientific themes will include (i) Biologic Underpinnings
of Clinical Heterogeneity; (ii) Immunological Mechanisms of Disease; (iii) Injury, Repair, and Fibrosis; and (iv)
Patient Outcomes/Experience and Innovative Trials. Trainees are also provided strong roots in the ethical
conduction of research, and in embracing a culture of diversity, equity, and inclusion. Some additional
highlights of the Training Program include: (i) the availability of an award-winning 10-week research training
course offered to physician trainees with a strong interest in basic research; (ii) multiple paths for trainees to
earn a master's degree concurrent with their Program training, and (iii) outstanding state-of-the-art biomedical
cores that provide training, consultations, and scientific services commensurate with U-M's standing as the top
public research institution in the United States. It has been a longstanding mission of our Program to train
individuals from diverse backgrounds for careers in research. Of the 26 trainees since 2009, 17 (65%) are
women and eight (31%) come from underrepresented backgrounds (1 Black, 5 Hispanic or Latinx, and
2 from disadvantaged backgrounds); half of the current trainees identify as underrepresented minorities. Of
the 20 trainees (9 MD and 11 PhD) who have completed their participation in our Program since 2011, all 20
remain involved in research. Fourteen of the 20 (70%) are working in research-intensive careers, and ten have
successfully competed for grant funding (~70 grants have been awarded to the group as PI).
项目总结/摘要
这个应用程序是密歇根大学的科学家培训计划的竞争性更新,
流变学研究(T32 AR 007080)。自1975年以来,我们的计划由NIAMS资助,旨在
每年培养四名优秀的博士后科学家,包括MD和PhD,从事以下研究工作:
与风湿性疾病有关的研究。我们的计划是由几个关键因素,包括(i)
巨大的临床需求所造成的无情的负担风湿性疾病;(ii)赞赏,
风湿性疾病是由需要多学科方法的复杂过程推动的;和(iii)
致力于风湿病学事业的各种研究人员的威胁管道
research.幸运的是,生物医学和临床科学的最新进展创造了前所未有的
研究机会,以更深入地了解疾病的病因,并最终改善结果
通过个性化的方法来照顾每个患有风湿性疾病的人。我们22
项目教师导师是专门的研究导师,他们共同带来了广泛的跨学科
专注于风湿性疾病的专业知识。这些研究人员已与
研究单位国内和国际上有效地研究风湿性疾病的机制,并提高
管理利用这些历史优势,我们的计划主题已经更新,以符合
NIAMS的战略使命是“通过跨领域的科学研究,
主题”。对于我们计划的下一个周期,主要科学主题将包括(i)生物基础
(ii)疾病的免疫机制;(iii)损伤、修复和纤维化;以及(iv)
患者结局/经验和创新试验。学员还提供了坚实的基础,在道德
进行研究,并拥抱多样性,公平和包容的文化。一些额外
培训计划的重点包括:(i)提供为期10周的获奖研究培训
为对基础研究有浓厚兴趣的医生学员提供的课程;(ii)为学员提供多种途径,
获得硕士学位的同时,他们的计划培训,和(iii)杰出的国家的最先进的生物医学
核心,提供培训,咨询和科学服务与密歇根大学的地位,作为最高的
美国的公共研究机构。我们项目的长期使命是
来自不同背景的人在研究的职业生涯。自2009年以来的26名受训人员中,17人(65%)是
女性和8名(31%)来自代表性不足的背景(1名黑人,5名西班牙裔或拉丁裔,
2名来自弱势背景);目前的受训人员中有一半认为自己是代表性不足的少数群体。的
自2011年以来,20名学员(9名医学博士和11名博士)已经完成了对我们计划的参与,所有20名学员都是在2012年完成的。
继续参与研究。这20人中有14人(70%)从事研究密集型职业,
成功竞争赠款资金(约70笔赠款已授予该集团作为PI)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jason Knight其他文献
Jason Knight的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jason Knight', 18)}}的其他基金
NETs as therapeutic targets in obstetric APS
NETs 作为产科 APS 的治疗靶点
- 批准号:
10786977 - 财政年份:2023
- 资助金额:
$ 35.34万 - 项目类别:
Purinergic modulation of the autoimmune vascular phenotype
自身免疫血管表型的嘌呤能调节
- 批准号:
10364621 - 财政年份:2018
- 资助金额:
$ 35.34万 - 项目类别:
Purinergic modulation of the autoimmune vascular phenotype
自身免疫血管表型的嘌呤能调节
- 批准号:
10168724 - 财政年份:2018
- 资助金额:
$ 35.34万 - 项目类别:
Purinergic modulation of the autoimmune vascular phenotype
自身免疫血管表型的嘌呤能调节
- 批准号:
10581346 - 财政年份:2018
- 资助金额:
$ 35.34万 - 项目类别:
Innate Immunity in the Pathogenesis of Lupus and Antiphospholipid Vasculopathy
狼疮和抗磷脂血管病发病机制中的先天免疫
- 批准号:
9392606 - 财政年份:2014
- 资助金额:
$ 35.34万 - 项目类别:
Innate Immunity in the Pathogenesis of Lupus and Antiphospholipid Vasculopathy
狼疮和抗磷脂血管病发病机制中的先天免疫
- 批准号:
8751822 - 财政年份:2014
- 资助金额:
$ 35.34万 - 项目类别:
相似海外基金
Listening to Patient Partners - From developing evidence-based tools for advancing meaningful patient engagement in research to now implementing them at an international organization for rheumatology research
倾听患者合作伙伴的意见 - 从开发基于证据的工具以促进患者有意义地参与研究,到现在在国际风湿病学研究组织中实施这些工具
- 批准号:
485116 - 财政年份:2023
- 资助金额:
$ 35.34万 - 项目类别:
Operating Grants
Inform Shared Decision-making with Advanced Bayesian Causal Inference to Improve Quality of Pediatric Rheumatology Care
通过高级贝叶斯因果推理为共享决策提供信息,以提高儿科风湿病护理的质量
- 批准号:
10646649 - 财政年份:2023
- 资助金额:
$ 35.34万 - 项目类别:
The Ontario Rheumatology Learning Health System for Transforming Integrated Care for Patients with Rheumatic and Musculoskeletal Disorders
安大略省风湿病学学习健康系统旨在转变风湿病和肌肉骨骼疾病患者的综合护理
- 批准号:
480460 - 财政年份:2022
- 资助金额:
$ 35.34万 - 项目类别:
Operating Grants
ACR Basic & Clinical Research Conference: Disrupting the Genetics of Rheumatology: The Role of Somatic Mutations in Health and Disease
ACR基础
- 批准号:
10540583 - 财政年份:2022
- 资助金额:
$ 35.34万 - 项目类别:
Advancing Safety Process Innovation in Rheumatology (ASPIRE)
推进风湿病学安全流程创新 (ASPIRE)
- 批准号:
10656161 - 财政年份:2022
- 资助金额:
$ 35.34万 - 项目类别:
Boston University Rheumatology Research Training (BURRT) T32 Program
波士顿大学风湿病学研究培训 (BURRT) T32 计划
- 批准号:
10623340 - 财政年份:2022
- 资助金额:
$ 35.34万 - 项目类别:
Advancing Safety Process Innovation in Rheumatology (ASPIRE)
推进风湿病学安全流程创新 (ASPIRE)
- 批准号:
10366101 - 财政年份:2022
- 资助金额:
$ 35.34万 - 项目类别:
Implementation of the Alberta Rheumatology Provincial Learning Health System
艾伯塔省风湿病学习健康系统的实施
- 批准号:
469957 - 财政年份:2022
- 资助金额:
$ 35.34万 - 项目类别:
Operating Grants
Boston University Rheumatology Research Training (BURRT) T32 Program
波士顿大学风湿病学研究培训 (BURRT) T32 计划
- 批准号:
10409984 - 财政年份:2022
- 资助金额:
$ 35.34万 - 项目类别: